Related Experiment Video
Updated: Jun 21, 2026
07:49
Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Cardiac hypertrophy: targeting Raf/MEK/ERK1/2-signaling
Kristina Lorenz1, Joachim P Schmitt, Marie Vidal
1Institute of Pharmacology and Toxicology, University of Würzburg, Versbacher Strasse 9, 97078 Würzburg, Germany. lorenz@toxi.uni-wuerzburg.de
The International Journal of Biochemistry & Cell Biology
|August 12, 2009
Summary
The ERK1/2 pathway regulates cardiac hypertrophy, a condition with both harmful and protective effects on the heart. Understanding these dual roles is key to developing new treatments for cardiac disease.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Cell Signaling
Background:
- The ERK1/2 signaling cascade is a complex network with critical roles in cardiac function.
- ERK1/2 signaling mediates cardiac hypertrophy, a process linked to heart failure, arrhythmias, and sudden death.
- ERK1/2 also confers beneficial effects, such as protection against ischemic injury and cell death.
Purpose of the Study:
- To review recent mechanistic insights into ERK1/2-dependent cardiac hypertrophy.
- To explore the potential of targeting ERK1/2's ambiguous functions for therapeutic strategies in cardiac disease.
Main Methods:
- Review of basic research findings over the past two decades.
- Analysis of regulatory mechanisms controlling the ERK1/2 signaling cascade.
- Discussion of the dual roles of ERK1/2 in cardiac hypertrophy.
Main Results:
- ERK1/2 signaling plays a dual role in cardiac hypertrophy, contributing to both detrimental outcomes and protective effects.
- Selective targeting of specific ERK1/2 functions presents a potential therapeutic avenue.
Conclusions:
- New mechanistic insights into ERK1/2 signaling are crucial for understanding cardiac hypertrophy.
- Translating this knowledge into therapeutic strategies could offer novel treatments for cardiovascular diseases.
Related Concept Videos
01:07MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:22PI3K/mTOR/AKT Signaling Pathway
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a rapamycin-insensitive companion...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include: